Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib
Bibliography
Li, B., Shin, H., Glubekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A., ... Schu, M. (2015). Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib. PLoS One.